ECP as prognostic Marker for Melanoma

被引：0
|
作者：
Moreira, A. [1 ]
Krueckel, A. [1 ]
Schuler, G. [1 ]
Utikal, J. [2 ]
Heinzerling, L. [1 ]
机构：
[1] Univ Klinikum Erlangen, Hautklin, Erlangen, Germany
[2] Univ Med Mannheim, Mannheim, Germany
来源：
JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT | 2019年 / 17卷
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
P08
引用
收藏
页码：27 / 28
页数：2
相关论文
共 50 条
  • [21] NM-23 EXPRESSION AS A PROGNOSTIC MARKER IN METASTATIC MELANOMA
    XERRI, L
    BATTYANI, Z
    BONERANDI, JJ
    HASSOUN, J
    GROB, JJ
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1995, 104 (01) : 159 - 159
  • [22] 2-Methoxyestradiol - A novel prognostic marker in malignant melanoma?
    Hrgovic, I.
    Kleemann, J.
    Doll, M.
    Loquai, C.
    Kaufmann, R.
    Meissner, M.
    EXPERIMENTAL DERMATOLOGY, 2018, 27 (03) : E24 - E24
  • [23] Expression of the SST receptor 2 in uveal melanoma is not a prognostic marker
    Mariam Kouch-el Filali
    Emine Kilic
    Marleen Melis
    Annelies de Klein
    Marion de Jong
    Gregorius P. M. Luyten
    Graefe's Archive for Clinical and Experimental Ophthalmology, 2008, 246
  • [24] Serum Amyloid A As a Prognostic Marker in Melanoma Identified by Proteomic Profiling
    Findeisen, Peter
    Zapatka, Marc
    Peccerella, Teresa
    Matzk, Heike
    Neumaier, Michael
    Schadendorf, Dirk
    Ugurel, Selma
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (13) : 2199 - 2208
  • [25] S 100 B: a prognostic marker in malignant melanoma.
    Hansson, LO
    Djuren, E
    Dijlai-Merzog, R
    Nilsson, B
    Hansson, J
    CLINICAL CHEMISTRY, 1998, 44 : A46 - A47
  • [26] NCOA3: A molecular prognostic marker for melanoma.
    Rangel, J.
    Torabian, S.
    Shaikh, L.
    Nosrati, M.
    Miller, J. R., III
    Sagebiel, R. W.
    Kashani-Sabet, M.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 454S - 454S
  • [27] Transcriptional regulation of the melanoma prognostic marker melastatin (TRPM1) by MITF in melanocytes and melanoma
    Miller, AJ
    Du, JY
    Rowan, S
    Hershey, CL
    Widlund, HR
    Fisher, DE
    CANCER RESEARCH, 2004, 64 (02) : 509 - 516
  • [28] Is tumor mutational burden a prognostic marker in AJCC stage II melanoma?
    Sinnberg, T.
    Niessner, H.
    Amaral, T.
    Eigentler, T.
    Schroeder, C.
    Lindner, E. S.
    Hilke, F. J.
    Bonzheim, I.
    Fend, F.
    Riess, O.
    Garbe, C.
    EXPERIMENTAL DERMATOLOGY, 2023, 32 (04) : E34 - E34
  • [29] c-myc is not useful as prognostic immunohistochemical marker in cutaneous melanoma
    Böni, R
    Bantschapp, O
    Müller, B
    Burg, G
    DERMATOLOGY, 1998, 196 (03) : 288 - 291
  • [30] BAP1 methylation: a prognostic marker of uveal melanoma metastasis
    Mathieu F. Bakhoum
    Ellis J. Curtis
    Michael H. Goldbaum
    Paul S. Mischel
    npj Precision Oncology, 5
12345